User menu

Urinary-excretion of Lead and Mercury After Oral-administration of Meso-2,3-dimercaptosuccinic Acid in Patients With Motor-neuron Disease

Bibliographic reference Louwerse, ES. ; Buchet, Jean-Pierre ; Vandijk, MA. ; Dejong, VJMB. ; Lauwerys, Robert. Urinary-excretion of Lead and Mercury After Oral-administration of Meso-2,3-dimercaptosuccinic Acid in Patients With Motor-neuron Disease. In: International Archives of Occupational and Environmental Health, Vol. 67, no. 2, p. 135-138 (1995)
Permanent URL
  1. Aposhian HV (1983) DMSA and DMPS ? water soluble antidotes for heavy metal poisoning. Ann Rev Pharmacol Toxicol 23: 193?215
  2. Arvidson B (1994) A review of axonal transport of metals. Toxicology 88: 1?14
  3. Barber TE (1978) Inorganic mercury intoxication reminiscent of amyotrophic lateral sclerosis. J Occup Med 20: 667?669
  4. Bensimon G, Lacomblez L, Meininger V, and the ALS/Riluzole Study Group (1994) A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 330: 585?591
  5. Conradi S, Ronnevi LO, Vesterberg O (1976) Abnormal tissue distribution of lead in amyotrophic lateral sclerosis. J Neurol Sci 29:259?265
  6. Conradi S, Ronnevi LO, Vesterberg O (1978a) Increased plasma levels of lead in amyotrophic lateral sclerosis compared to controls, as determined by flameless atomic absorption spectrophotometry. J Neurol Neurosurg Psychiatry 41: 389?393
  7. Conradi S, Ronnevi LO, Vesterberg O (1978b) Lead concentration in skeletal muscle in amyotrophic lateral sclerosis patients and control subjects. J Neurol Neurosurg Psychiatry 41: 1001?1004
  8. Currier RD, Haerer AF (1968) Amyotrophic lateral sclerosis and metallic toxins. Arch Environ Health 17: 712?719
  9. Gurney ME, Pu H, Chin AY, del Canto MC, Polchow CY, Alexander J, Caliendo J, Hentati A, Kwon YW, Deng HX, Chen W, Zhai P, Sufit RL, Siddique T (1994) Motor neuron degeneration in mice that expresses a human Cu, Zn superoxide dismutase mutation. Science 264: 1772?1774
  10. Lauwerys R, Hoet P (1993) Industrial chemical exposure. Guidelines for biological monitoring, 2nd edn. Lewis, Boca Raton, Fl. USA pp 55?70
  11. Magos L, Clarkson TW (1972) Atomic absorption determination of total, inorganic, and organic mercury in blood. J Assoc Off Anal Chem 55: 966?971
  12. Pamphlett R, Bayliss A (1992) Lead uptake in motor axons. Muscle Nerve 15: 620?625
  13. Petkau A, Sawatzki A, Hillier CR, Hoogstraten J (1974A) Lead content of neuromuscular tissue in amyotrophic lateral sclerosis: case report and other consideration. Br J Ind Med 31: 275?287
  14. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Van den Bergh R, Hung WY, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau G, Gusella JS, Horvitz HR, Brown Jr RH (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59?62
  15. Schionning JD, Eide R, Moller-Madsen B, Ernst E (1993) Detection of mercury in rat spinal cord and dorsal root ganglia after exposure to mercury vapor. Exp Mol Pathol 58: 215?228
  16. Sillevis Smitt PAES, Blaauwgeers HGT, Troost D, de Jong JMBV (1992) Metallothionein immunoreactivity is increased in the spinal cord of patients with amyotrophic lateral sclerosis. Neurosci Lett 144: 107?110
  17. Zinterhofer IJ, Jatlow PI, Anthony F (1971) Atomic absorption determination of lead in blood and in urine in the presence of EDTA. J Lab Clin Med 78: 664?674